Background Anti-tumour necrosis factor (anti-TNF) therapy has been associated with reports
of rapid severe progression of rheumatoid arthritis-associated interstitial lung disease (RA …

Objective This study explores whether the prognosis of interstitial lung disease in
rheumatoid arthritis (RA-ILD) has improved over time and assesses the potential influence of …

Objectives: To describe a prospective cohort of patients with rheumatoid arthritis associated
with interstitial lung disease (RA-ILD) and identify risk factors associated with disease …

Objectives: Interstitial lung disease (ILD) is an important complication of rheumatoid arthritis
(RA) or its treatment, and is associated with substantially increased mortality. Reports have …

Objectives To analyze the effect of disease-modifying antirheumatic drugs (DMARDs) on the
outcome of interstitial lung disease secondary to rheumatoid arthritis (RA-ILD). Patients and …

Objectives To compare mortality risks in patients with rheumatoid arthritis-associated
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …

Background Interstitial lung disease (ILD) is a common and potentially life-threatening
complication for rheumatoid arthritis (RA) patients. However, there is a lack of clear …

Objectives: This study evaluated the correlation between tumor necrosis factor alpha
inhibitor (TNF-I) and interstitial lung disease (ILD) in rheumatoid arthritis (RA). We aimed to …

Background Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is associated
with high levels of morbidity and mortality. The primary aim of this systematic review was to …

Objectives Guidelines cautioned prescribing of tumour necrosis factor inhibitors (TNFi) to
patients with rheumatoid arthritis and interstitial lung disease (RA-ILD) after reports of new or …